Results 171 to 180 of about 2,868,828 (304)

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Child undernutrition in Kenya: trend analyses from 1993 to 2008-09. [PDF]

open access: yesBMC Pediatr, 2014
Matanda DJ, Mittelmark MB, Kigaru DM.
europepmc   +1 more source

Bibliometric analyses on repository contents as a library service for the evaluation of research [PDF]

open access: yes
Since the last two decennia, the library of Wageningen University and Research (or Wageningen UR) has been involved in several bibliometric analyses for the evaluation of scientific output of staff, chair groups, research institutes and graduate schools.
Gerritsma, W., Veller, M.G.P., van
core   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Trend analyses of insulin delivery systems in the United States. [PDF]

open access: yesJ Diabetes Sci Technol, 2011
Lee LJ, Li Q, Reynolds MW, Engelman W.
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Multilevel and spatial-time trend analyses of the prevalence of hypertension in a large urban city in the USA. [PDF]

open access: yesJ Urban Health, 2013
Liu L   +5 more
europepmc   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy